Mayer Hasbani, MD
Clinical Neurophysiology · New Haven, CTNPI 1780632968
Payments from drug & device makers
Across 3,421 payments — averaging $375.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$412K
- Ipsen Pharma SAS$211K
- AbbVie$78K
- Otsuka America Pharmaceutical, Inc.$74K
- Teva Pharmaceuticals USA, Inc.$60K
- Eisai Inc.$57K
- plus $389K from 54 others
What the payments were for
- Consulting fees$51,7099%
- Speaking & faculty fees$421,72072%
- Grants$880%
- Travel & lodging$31,6975%
- Food & beverage$75,50013%
- Education$1,6850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical neurophysiology providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammakedImmune Globul G/Gly/Iga Avg 46 | 17 | $393,961 |
| AustedoDeutetrabenazine | 56 | $391,841 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 13 | $216,039 |
| NuplazidPimavanserin Tartrate | 30 | $157,563 |
| BotoxOnabotulinumtoxina | 75 | $90,430 |
| QuliptaAtogepant | 56 | $58,542 |
| Glatiramer Acetate | 13 | $57,249 |
| Aimovig AutoinjectorErenumab-Aooe | 52 | $49,864 |
| Lamictal XrLamotrigine | 24 | $43,623 |
| XcopriCenobamate | 34 | $41,061 |
| RytaryCarbidopa/Levodopa | 23 | $39,783 |
| RexultiBrexpiprazole | 23 | $33,991 |
| Nurtec OdtRimegepant Sulfate | 21 | $30,945 |
| Rasagiline Mesylate | 198 | $28,790 |
| BriviactBrivaracetam | 22 | $28,133 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $59,579 | $391,84156 claims |
| Grifols USA, LLCGamunex-C | $510 | $216,03913 claims |
| Acadia Pharmaceuticals IncNuplazid | $5,172 | $157,56330 claims |
| AbbVieBotox, Qulipta, Linzess | $78,151 | $154,828142 claims |
| PfizerNurtec Odt, Lyrica | $912 | $49,34443 claims |
| SK Life Science, Inc.Xcopri | $2,609 | $41,06134 claims |
| Amneal Pharmaceuticals LLCRytary | $2,546 | $39,78323 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $74,196 | $33,99123 claims |
| UCB, Inc.Briviact | $1,547 | $28,13322 claims |
| Eisai Inc.Fycompa | $56,788 | $22,91518 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $29,254 | $20,72913 claims |
| Neurocrine Biosciences, Inc.Ongentys | $1,248 | $8,57613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical neurophysiology providers in Connecticuton file to place this against a meaningful peer group, so we don't.
Other clinical neurophysiology in New Haven
- Bogdan Patedakis LitvinovNew Haven$117K
- Bahman JabbariNew Haven$31K
- Moshe HasbaniNew Haven$10K
- Adithya SivarajuNew Haven$108
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.